Two thirds of breast cancer cases express estrogen (ER) and/or progesterone receptors (PgR) [12–14]; positivity of estrogen or progesterone receptors in breast cancer has been related to the efficacy of tamoxifen, as well as AIs. The gene discussed is PGR; the disease is breast cancer.